康华生物 (300841.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(康华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) 1.001.001.001.001.001.001.002.00
 单季度销售毛利率(%) 93.0094.0094.0094.0093.0093.0094.0094.00
 单季度销售净利率(%) 24.0034.0040.0038.0029.0042.0046.0051.00
 单季度净资产收益率ROE(%) 4.004.004.003.004.006.006.005.00
 单季度总资产净利率ROA(%) 3.003.004.003.003.005.006.004.00
单季度财务摘要:
 单季度营业总收入(元) 587,340,379.00355,615,965.00356,325,028.00278,114,029.00392,176,173.00394,777,765.00393,034,749.00266,736,075.00
 单季度营业总成本(元) 373,013,618.00223,032,856.00196,615,913.00166,597,333.00275,181,558.00208,627,769.00177,144,211.00120,171,079.00
 单季度营业收入(元) 587,340,379.00355,615,965.00356,325,028.00278,114,029.00392,176,173.00394,777,765.00393,034,749.00266,736,075.00
 单季度营业利润(元) 168,085,874.00130,404,127.00161,084,173.00117,037,988.00134,564,286.00189,295,288.00205,507,811.00156,134,499.00
 单季度利润总额(元) 165,962,308.00130,135,727.00161,006,535.00116,889,025.00133,918,018.00189,356,456.00204,384,143.00156,134,338.00
 单季度净利润(元) 140,277,874.00120,733,208.00143,014,266.00105,190,617.00114,753,157.00167,636,572.00180,399,240.00135,277,247.00
 单季度归属母公司股东的净利润(元) 140,277,874.00120,733,208.00143,014,266.00105,190,617.00114,753,157.00167,636,572.00180,399,240.00135,277,247.00
 单季度经营活动产生的现金流量(元) 308,975,817.00143,242,365.00104,873,064.0016,892,088.00175,363,809.0086,617,509.0044,814,817.00-111,805,583.00
 单季度投资活动产生的现金流量(元) -51,395,368.00-27,517,389.00-23,876,578.00-60,600,015.00-112,190,525.00-133,156,790.004,467,329.00-171,578,870.00
 单季度筹资活动产生的现金流量(元) 46,831,831.00-14,995,230.00-61,679,321.0022,725,357.00-9,820,838.00-6,565,821.00-92,052,733.0034,874,463.00
 单季度现金及现金等价物净增加(元) 304,377,976.00100,695,985.0019,325,892.00-20,992,307.0053,372,682.00-53,044,160.00-42,740,204.00-248,508,570.00

前瞻产业研究院